JACKSONVILLE, Fla.--(BUSINESS WIRE)--Next Science (ASX:NXS), an innovative medical technology company that is the leader in treating biofilm-based infections in humans, announced today that it has donated $300,000 worth of BlastX™ Antimicrobial Wound Gel to Hampton Ridge Healthcare and Rehabilitation in Toms River, New Jersey. This gift is part of a $500,000 donation program with 3M Company, the exclusive distributor of BlastX™, that helps caregivers treat patients suffering from chronic wounds at nursing and rehabilitative care facilities.
“Wound care is crucial for patients in long-term care facilities, particularly for aging patients,” said Dustin Haines, chief commercial officer for Next Science. “This donation is one way we can help frontline caregivers provide the best treatment possible and deliver on our mission to heal people and save lives with our innovative technologies.”
The support to Hampton Ridge is the latest of several donations of BlastX™ that Next Science and 3M will make to long-term care facilities. Previously, the company set up donation programs to help patients who were unable to receive treatment at wound care clinics that were closed as a result of COVID-19.
“With Next Science’s BlastX™ gel, we can be sure patients receive the best care possible to treat chronic wounds and mitigate infection by preventing bacterial resistance,” said Dr. Matthew Regulski, DPM, a surgeon who regularly treats patients at Hampton Ridge Healthcare and Rehabilitation. “We are grateful to Next Science and their generous support in treating current and future patients at our facility.”
BlastX™ is a breakthrough antimicrobial wound gel that is powered by Next Science’s patented, non-toxic, biofilm-disruption Xbio™ technology. BlastX™ breaks down biofilm, destroys bacteria within the gel and defends against reinfection.
Biofilm, which is a naturally occurring substance, accounts for a significant percentage of hard-to-manage bacterial proliferations worldwide. The Centers for Disease Control and Prevention estimate that 80% of infections in humans are located in biofilm. In the U.S., these infections contribute to approximately 500,000 deaths each year and cost an estimated $94 billion to treat.
About Next Science
Next Science is a medical technology company headquartered in Sydney, Australia, with a research and development center based in Jacksonville, Florida. Established in 2012, the company’s primary focus is on the development and continued commercialization of its proprietary Xbio™ technology to reduce the impact of biofilm-based infections in human health. Xbio™ is a unique, non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Next Science owns 100% of the patent protected intellectual property relating to its Xbio™ technology. For further information visit: www.nextscience.com.
About Hampton Ridge Healthcare and Rehabilitation
Hampton Ridge Healthcare and Rehabilitation is one of New Jersey’s premier centers for skilled nursing and rehabilitative care. Hampton Ridge is a comprehensive nursing care facility, providing a full range of healthcare services, including rehabilitative therapy, skilled nursing care, post-surgical care, long-term care, Alzheimer’s and dementia care, as well as respite and palliative care. Hampton Ridge offers outstanding healthcare in a comfortable and pleasant environment with beautiful accommodations and fine amenities. The facility is located in Tom River. For further information visit: https://hamptonridgehealth.com.
About 3M
At 3M, we apply science in collaborative ways that improve lives daily. With $32 billion in sales, our 96,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at http://www.3m.com/ or on Twitter @3M or @3MNews.
